Annual Drug Patent Expirations for CHILDREN%27S+ALLEGRA+HIVES For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit www.DrugPatentWatch.com
The post New pat…
New patent expiration for Sanofi Aventis drug CHILDREN’S ALLEGRA HIVES Read Post »
Annual Drug Patent Expirations for CHILDREN%27S+ALLEGRA+ALLERGY For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit www.DrugPatentWatch.com
The post New p…
New patent expiration for Sanofi Aventis drug CHILDREN’S ALLEGRA ALLERGY Read Post »
Annual Drug Patent Expirations for JAKAFI Jakafi is a drug marketed by Incyte Corp and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent for Incyte Corp drug JAKAFI appeared first on DrugPatentWatch…
Annual Drug Patent Expirations for SELZENTRY Selzentry is a drug marketed by Viiv Hlthcare and is included in two NDAs. It is available from one supplier. There are three patents…
The post New patent expiration for Viiv Hlthcare drug SELZENTRY appeared…
New patent expiration for Viiv Hlthcare drug SELZENTRY Read Post »
This chart shows the drugs with the most patents in Cyprus. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Cyprus? …
Which pharmaceutical drugs have the most drug patents in Cyprus? Read Post »
Annual Drug Patent Expirations for PROMACTA+KIT Promacta Kit is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are seven patents…
The post New patent expiration for Novartis drug PROMACTA KIT appeared f…
New patent expiration for Novartis drug PROMACTA KIT Read Post »
Annual Drug Patent Expirations for PROMACTA Promacta is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There are twelve patents protecting…
The post New patent expiration for Novartis drug PROMACTA appeared …
New patent expiration for Novartis drug PROMACTA Read Post »
This chart shows the drugs with the most patents in European Patent Office. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…
The post Which pharmaceutical drugs have the most drug patents in Euro…
Which pharmaceutical drugs have the most drug patents in European Patent Office? Read Post »
PROMACTA (eltrombopag olamine) Novartis Patent: 7,452,874 Expiration: Nov 24, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug…
Drug Patent Expirations for the Week of November 21, 2021 Read Post »
Annual Drug Patent Expirations for MAKENA+%28AUTOINJECTOR%29 Makena (autoinjector) is a drug marketed by Covis and is included in one NDA. It is available from two suppliers. There are eight patents…
The post New patent for COVIS drug MAKENA (AUTOINJEC…
Get new actionable insights and updates from BiotechBlog
